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The performance of a direct sandwich enzyme-linked immunosorbent assay (ELISA) for detecting Aspergillus 
galactomannan was compared with that of the Pastorex Aspergillus antigen latex agglutination (LA) test by 
using 532 serum samples from 61 patients at risk for invasive aspergillosis. The ELISA gave positive results 
earlier in the course of infection than did the LA test. A sensitivity of 70% and a specificity of 86% were obtained 
for the LA test and corresponding values of 90 and 84% were obtained for the ELISA when a series of serum 
samples was employed.
Aspergillus fumigatus is a ubiquitous fungus capable of caus­
ing life-threatening opportunistic infections in immunocom­
promised patients (3). Inhalation of airborne Aspergillus 
conidia and germination of spores in the alveoli primarily re­
sult in pulmonary infection, although dissemination to other 
organs may occur. The successful diagnosis of invasive as­
pergillosis (IA) is frustrated by the difficulty in obtaining spec­
imens which demonstrate the organism directly. Serologic 
techniques have been used in an attempt to establish diagnosis 
in early stages of infection but have proven to be unsuccessful 
for immunocompromised patients because of the patients’ im­
paired ability to produce humoral responses. The detection of 
circulating Aspergillus antigens in body fluids, e.g., in serum 
and urine, is promising, but despite the development of several 
methods for such detection (1, 8), none has gained widespread 
acceptance. Recently, a direct double sandwich enzyme-linked 
immunosorbent assay (ELISA) has been developed; this assay 
employs the rat monoclonal antibody EB-A2 to detect galac­
tomannan (GM), a cell wall component of Aspergillus spp. ('15,
16). The EB-A2 antibody is also used in the commercially 
available Pastorex Aspergillus latex agglutination (LA) test 
(Sanofi Diagnostics Pasteur, Marnes-La-Coquette, France) 
(16), but the detection limit can be lowered 10-fold by employ­
ing the antibody as a captor and a detector (15), which may 
allow IA to be diagnosed earlier. We investigated this possi­
bility by testing the ELISA with a series of 532 serum samples 
which had been previously analyzed by LA (18) to attempt to 
diagnose IA in 61 immunocompromised patients at high risk 
for the disease.
A total of 532 serum samples from 61 patients were collected 
during chemotherapy-induced neutropenia and were stored at 
—80°C At least two serum samples were available from each 
patient. Before testing, all serum samples were treated as de­
scribed previously for Candida mannan (13) to dissociate im­
mune complexes. All LA tests were performed by the same 
technician exactly as described by the manufacturer. For the 
ELISA, the supernatants of the serum samples were obtained
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by centrifuging the samples at 15,000 X g for 10 min. The 
ELISA was performed as described previously (15). Briefly, 50 
fxl of the treated sample and 50 j jl I of horseradish peroxidase- 
conjugated EB-A2 were placed in the wells of a microtiter 
plate coated with monoclonal antibody EB-A2, and the plates 
were incubated at 37°C for 90 min. After the plates were 
washed, 100 jxl of buffer containing 0rt/?0-phenylenediamine 
dihydrochloride was added to the wells, and the plates were 
incubated for 30 min. The reaction was stopped with 50 jjl I of
4 M sulfuric acid, and the optical density was read at 492 nm. 
The optical density of antigen-negative serum spiked with 1 ng 
of GM per ml provided the cutoff value (15), and a positive and 
a negative control were included with each test.
The results for the 532 serum samples tested by LA and 
ELISA are shown in Table 1. A total of 325 serum samples 
were obtained from 33 patients who had a low likelihood of IA,
i.e., patients for whom there was no clinical, microbiological, 
histological, or radiological evidence of infection. Three sam­
ples were positive in both tests, 2 samples (1.5%) were positive 
in the LA test alone, and 22 samples (7.7%) were positive only 
in the ELISA. There was clinical evidence of IA in the other 28 
patients, who had all developed pulmonary infiltrates and had 
been febrile (temperatures of >38°C) for 3 days despite broad- 
spectrum antimicrobial therapy. For 18 of these patients, the 
courses of infection and the results of cultures suggested that 
LA was unlikely. With the 120 serum samples from these 18 
patients, positive results were obtained for 3 samples (2.5%) in 
both tests and 10 samples (8.3%) were positive by ELISA 
(Table 1). The clinical characteristics of the remaining 10 pa­
tients with possible IA (patients showing clinical and radiolog­
ical evidence for IA but having negative culture results) or 
proven IA (patients showing histopathological evidence of tis­
sue invasion at autopsy and having positive Aspergillus culture 
results) are shown in Table 2, together with the results of the 
analyses of 87 serum samples from these patients. GM was not 
detected by either test in any of the serum from patient 1, who 
had a proven infection. Very low levels of GM in serum, due to 
limited fungal invasion of the pulmonary blood vessels or the 
release of low levels of GM by the fungus into the body fluids, 
may have contributed to the false-negative result for this pa­
tient. For the entire patient population, the sensitivity and 
specificity of the LA test were 70 and 86%, respectively, and
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TABLE 1. Performance of the double-sandwich ELISA and the Pastorex LA test for diagnosis of IA
Test (result)
Patient group
Low index of suspicion for IA" IA suspected but unlikely4* High index of suspicion for IA'"'
No. of 
patients
No. of positive 
samples/no. of 
samples analyzed
No. of 
patients
No. of positive 
samples/no. of 
samples analyzed
No. of 
patients
No. of positive 
samples/no. of 
samples analyzed
LA (+) 4 5/35 3 3/27 7 16/52
LA ( - ) 29 0/290 15 0/93 3 0/35
ELISA7 (+) 10 25/88 5 10/41 9 58/85
ELISA ( - ) 23 0/237 13 0/79 1 0/2
ELISA" (+) 5 20/52 3 8/33 9 58/85
ELISA ( - ) 28 5/273 15 2/87 1 0/2
" Patients in this group showed no clinical, microbiological, histological, or radiological evidence of infection, n =  33, 
b Patients in this group showed fever and pulmonary infiltrates, but culture results and courses of infection suggested that IA was unlikely, n 
c Patients in this group had histopathological, radiological, or microbiological evidence of TA. n =  10, 
d A  patient was considered positive when one or more serum samples was positive by ELISA. 
c A patient was considered positive when two or more consecutive serum samples were positive by ELISA.
= 18.
the sensitivity and specificity of the ELISA were 90 and 71%, 
respectively. When a true-positive result for the ELISA was 
defined as two consecutive positive serum samples, the sensi­
tivity was similar (90%) but the specificity increased to 84%.
Diagnosing IA at an early stage of infection is difficult. The 
culture of Aspergillus spp. from the sputa or bronchoalveolar 
lavage fluids of patients at high risk for IA is highly indicative 
of infection, but the diagnostic reliability of culture is low (11). 
Therefore, more-sensitive methods, such as PCR (10, 12, 14,
17) and Aspergillus antigen detection (2, 4-9, 15, 18, 19), are 
under investigation. The detection of GM by the Pastorex 
Aspergillus LA test has been evaluated at several institutes (2, 
4-7, 9, 18, 19), and the test showed sensitivities of up to 95% 
with serum samples from patients with a high index of suspi­
cion for IA (4, 5). The LA test was also found to yield positive 
results earlier than conventional tests for 68% of patients with 
proven LA (5). However, these observations were not con­
firmed by others (2, 6, 7, 9, 18, 19), and a sensitivity of only 
38% has been reported (9). In our study, the LA test yielded 
positive results only during advanced stages of infection in 
most patients with suspected IA and did not contribute to an 
earlier diagnosis (18). The present study showed that the 
ELISA detected GM in serum up to 5 days earlier than the LA 
test did. Although both LA and ELISA failed to detect one 
proven infection, the ELISA detected GM in two additional 
patients for whom the LA test continued to yield negative 
results. Moreover, GM was detected in more serum samples by 
ELISA than by LA. This suggests that monitoring sequential 
serum samples from high-risk patients during neutropenia may 
allow the diagnosis of IA to be made at an earlier stage of 
infection.
The increased sensitivity of the ELISA, however, was asso­
ciated with an increase in false-positive results. A rate of 8% 
false positives by ELISA has been found by others (15). There­
TABLE 2. Clinical characteristics and serum analyses of 10 neutropenic patients with proven or possible IA
Patient
no.
Sex7age
(yr)
Underlying condition(s)h Aspergillus infection“1'
No. of serum 
samples 
tested
No. positive 
by LA
No. positive 
by ELISA
Time (days) 
between fever 
and positive 
test by**:
LA ELISA
1 F/33 AML Proven, bronchopneumonia 2 0 0
2 M/30 AML Proven, cavitating 19 5 17 -1-10 +7
bronchopneumonia
3 F/44 AML, BMT Proven, bronchopneumonia 5 3 5 + 12 +9
4 F/60 Kidney transplant Proven, disseminated 2 1 2 +14 +9
5 P/51 MDS, BMT Proven, disseminated 12 1 7 + 10 +7
6 M/58 Hepatocellular carcinoma Proven, bronchopneumonia 2 2 2 + 4 +4
7 M/53 CML, BMT Possible 9 1 8 + 16 + 13
8 F/50 CML, BMT Possible 15 0 6 —5
9 M/38 CML, BMT Possible 18 0 8 - 4
10 M/37 AIDS Possible 3 3 3 + 90 + 90
Total 87 16 58
" F, female; M, male.
b AML, acute myeloid leukemia; BMT, bone marrow transplantation; MDS, myelodysplastic syndrome; CML, chronic myeloid leukemia, All patients died. 
c “Proven” refers to patients with histopathological evidence of tissue invasion and positive Aspergillus cultures. “Possible” indicates that cultures from sputa or 
bronchoalveolar lavage fluids were negative for Aspergillus species but clinical and radiological evidence for IA was present.
d Values are numbers of days elapsed between the first day of fever (temperature of >38,5°C) and a positive result by either test. Patient 9 developed severe 
graft-versus-host disease (III) and was treated with high doses of corticosteroids. With patient 10, a fever of unknown origin was present for 3 months, but 3 days before 
the first serum sample was obtained, respiratory failure developed and infiltrates were demonstrated by chest roentgenogram.
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fore, in order to identify a genuine elevation of the GM level 
in serum, positive ELISA results should be found for at least 
two consecutive serum samples.
Our results suggest that antigen detection at regular inter­
vals by the double sandwich ELISA may allow the early diag­
nosis of IA in immunocompromised patients. Twice-weekly 
collection and testing of serum samples from a patient during 
the period of neutropenia should be sufficient to detect an 
increase in the GM level in serum early in the course of 
infection. In the case of a positive ELISA result, the collection 
and testing of serum samples should be continued in order to 
exclude the possibility of a false-positive result. Furthermore, 
confirmation of suspected IA should be obtained by chest 
roentgenogram, computer tomography, or bronchoalveolar la­
vage. Prospective studies following these guidelines are needed 
to establish the clinical value of this new ELISA.
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